We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

146 hedge funds and large institutions have $242M invested in Alaunos Therapeutics in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 32

29% more call options, than puts

Call options by funds: $4.41M | Put options by funds: $3.42M

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.01% less ownership

Funds ownership: 0.32% → 0.31% (-0.01%)

1% less funds holding

Funds holding: 148 → 146 (-2)

40% less capital invested

Capital invested by funds: $404M → $242M (-$162M)

Holders
146
Holders Change
-2
Holders Change %
-1.35%
% of All Funds
3.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
54
Reduced
32
Closed
23
Calls
$4.41M
Puts
$3.42M
Net Calls
+$989K
Net Calls Change
+$5.83M

Top Buyers

Rank Fund Capital Flow
1
DCM
Discovery Capital Management
Connecticut
+$16.7M
2
EC
EcoR1 Capital
California
+$12.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.84M
4
BlackRock
BlackRock
New York
+$5.01M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.29M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.74M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.87M
3
Group One Trading
Group One Trading
Illinois
-$901K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$639K
5
Squarepoint
Squarepoint
New York
-$626K
Name Holding Trade Value Shares
Change 		Change in
Stake
AGM
151
Alpine Global Management
New York
– -$108K -153 Closed
JG
152
Jefferies Group
New York
– -$92K -130 Closed
ARTA
153
A.R.T. Advisors
New York
– -$86K -122 Closed
NIT
154
NumerixS Investment Technologies
British Columbia, Canada
– -$51K -72 Closed
ODG
155
O'Dell Group
Ohio
– -$48K -68 Closed
WHG
156
Westwood Holdings Group
Texas
– -$42K -59 Closed
SC
157
Sculptor Capital
New York
– -$25K -35 Closed
Chevy Chase Trust
158
Chevy Chase Trust
Maryland
– -$24K -33 Closed
OSAM
159
O'Shaughnessy Asset Management
Connecticut
– -$12K -17 Closed
1IA
160
1834 Investment Advisors
Wisconsin
– -$9K -13 Closed
EWM
161
EPG Wealth Management
Georgia
– -$9K -13 Closed
PA
162
PSI Advisors
Florida
– -$4K -7 Closed
LWM
163
Lionsbridge Wealth Management
Florida
– -$3K -5 Closed
GWMIA
164
Global Wealth Management Investment Advisory
Florida
– -$2K -3 Closed
Fidelity Investments
165
Fidelity Investments
Massachusetts
– -$1K -1 Closed
II
166
Inspire Investing
Idaho
– +$517 +1 New
3 4 5 6
7

TCRT Hedge Fund Activity: Q1 2020 in Review

146 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q1 2020, worth a combined $242M — down 40% from $404M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new TCRT positions and 23 closed out — a net gain of 1 holder — while 54 added to existing stakes and 32 trimmed.

The largest buyer was Discovery Capital Management, adding an estimated $16.7M. The largest seller was Millennium Management, cutting an estimated $4.74M.

  • 146 institutional investors held Alaunos Therapeutics (TCRT) as of Q1 2020, down from 148 in Q4 2019.
  • Funds reported $242M of Alaunos Therapeutics stock for Q1 2020, down 40% quarter-over-quarter.
  • 24 funds opened new Alaunos Therapeutics positions in Q1 2020 and 23 closed out, a net change of +1 holder.
  • The largest Alaunos Therapeutics buyer in Q1 2020 was Discovery Capital Management, an estimated $16.7M added.
  • The largest Alaunos Therapeutics seller in Q1 2020 was Millennium Management, an estimated $4.74M sold.

Based on aggregated 13F filings for Q1 2020.